Scott, Stuart D <br/><br/>
Assessment of plasma cell myeloma minimal residual disease testing by flow cytometry in an international inter-laboratory study: Is it ready for primetime use?  [electronic resource] 

 -  Cytometry. Part B, Clinical cytometry  05 2019 
 - 201-208 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1552-4957 
<br/><br/><label>Standard No.: </label>10.1002/cyto.b.21754  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Bone Marrow Cells--immunology<br/>Flow Cytometry--methods<br/>Humans<br/>International Cooperation<br/>Laboratory Proficiency Testing<br/>Limit of Detection<br/>Lymphocyte Count<br/>Multiple Myeloma--diagnosis<br/>Neoplasm, Residual<br/>Observer Variation<br/>Plasma Cells--immunology<br/>Practice Guidelines as Topic<br/>Prognosis<br/>Recurrence<br/>Survival Analysis